Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Allergan Limited
Woman and Man Max 99 years
Allergan Limited
Update Il y a 4 ans
A 6-Week, Multicenter, Masked, Randomized Trial (with a 20-Week Masked Extension) to Assess the Safety and Efficacy of 700 µg and 350 µg Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Applicator System Compared with Sham DEX PS DDS Applicator System in the Treatment of Non Infectious Ocular Inflammation of the Anterior Segment in Patients with Anterior Uveitis
To evaluate the safety and efficacy of the 700 µg DEX PS DDS Applicator System (700 µg dexamethasone) and 350 µg DEX PS DDS Applicator System (350 µg dexamethasone) compared with Sham DEX PS DDS Appli...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Allergan Limited
Update Il y a 4 ans
A Double-Blind, Randomised, Cross-over, Safety and Efficacy Pilot Study Comparing Two Botulinum Toxin Type-A Products in the Treatment of Moderate to Severe Cervical Dystonia
Primary Objective To compare the efficacy of intramuscular BOTOX® versus Xeomin® in the treatment of moderate to severe cervical dystonia.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Allergan Limited
Update Il y a 4 ans
A study to compare a slow release formulation of bimatoprost with selective laser trabeculoplasty in patients with open-angle glaucoma or high pressure in the eye Un estudio para comparar una formulación de Bimatoprost de liberación prolongada con trabeculoplastia selectiva con láser en pacientes con glaucoma de ángulo abierto o hipertensión ocular
To evaluate the IOP-lowering effect and safety of Bimatoprost SR compared with SLT in patients with OAG or OHT, who are not adequately managed with topical IOP-lowering medication for reasons other th...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Allergan Limited
Update Il y a 4 ans
Treatment of Spasticity in the upper limb in children
To evaluate the long-term safety of repeated doses of BOTOX for the treatment of pediatric upper limb spasticity.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Allergan Limited
Update Il y a 4 ans
A Multicenter, Patient-Masked, Safety Extension Study to Evaluate the Biodegradation of the Brimonidine Tartrate Posterior Segment Drug Delivery System
To evaluate the biodegradation and related safety profile of the intravitreal Brimonidine Tartrate Posterior Segment Drug Delivery System (Brimo PS DDS®) Implant
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Allergan Limited
Update Il y a 4 ans
Clinical Study of the safety and efficacy of Bimotoprost 0.03%/Timolol 0.5% Preservative-free Ophthalmic Solution compared with GANFORT®(Bimotoprost 0.03%/Timolol 0.5% Ophthalmic Solution) once daily for 12 weeks in Patients with Glaucoma or Ocular Hypertension
To compare the efficacy and safety of bimatoprost 0.03%/ timolol 0.5% PF ophthalmic solution with GANFORT once-daily use for 12 weeks in patients with glaucoma or ocular hypertension (OHT). To show t...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Allergan Limited
Update Il y a 4 ans
BOTOX® Treatment in Adult Patients with Upper Limb Spasticity
To evaluate the safety and efficacy of BOTOX 300 U and 500 U in the treatment of spasticity involving the muscles of the elbow and shoulder of adult poststroke patients.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Allergan Limited
Update Il y a 4 ans
A Multicenter, Masked, Randomized, Sham-controlled, Paired-eye Comparison, 12-Month (Plus 12-Month Extension) Study to Evaluate the Safety and Effects on Retinal Structure and Visual Function of Brimonidine Tartrate Posterior Segment Drug Delivery System (Brimonidine Tartrate PS DDS) Applicator System in Patients with Geographic Atrophy from Age-related Macular Degeneration
To evaluate the safety of the Brimo PS DDS Applicator System (200 μg and 400 μg brimonidine tartrate) in patients with geographic atrophy (GA) from age-related macular degeneration (AMD) To evaluat...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Allergan Limited
Update Il y a 4 ans
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Extension Study to Evaluate the Safety and Efficacy of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex in Subjects with Facial Rhytides (Crow’s Feet Lines and Glabellar Lines)
To evaluate the safety and efficacy of BOTOX compared to placebo in subjects with lateral canthal rhytides in the periorbital region (CFL).
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Allergan Limited
Update Il y a 4 ans
BOTOX® in the Treatment of Urinary Incontinence Due to Overactive Bladder in Patients 12 to 17 Years of Age
To evaluate the safety and efficacy of BOTOX for the treatment of urinary incontinence due to OAB in patients 12 to 17 years of age who have not been adequately managed with anticholinergic therapy. T...
Country
None
organs
None
Specialty
None
unknown
More information
1
2
3
4
Next